Are you working on these ATMP's or clearing a path to continuous biologics manufacturing? ISPE invites you to submit a proposal for our 2018 ISPE Biopharmaceutical Manufacturing Conference , December 10-12, Huntington Beach, CA
The 2018 ISPE Biopharmaceutical Manufacturing Conference focuses on the quickly evolving science of biologics manufacturing for new modalities, and the novel technologies that leverage existing capacity and move us towards continuous manufacturing. Share your expertise and help your peers prepare to manufacture these novel medicines and deliver on our promise of supplying life changing medicines to patients across the globe.
The call for proposals is open until May 30, 2018.
I speak for all the conference committee volunteers when I say we look forward to reading your proposals and learning how you are propelling the industry forward.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...